Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements

Detalles Bibliográficos
Autores principales: Lin, Chien-Ju, Wason, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660152/
http://dx.doi.org/10.1186/1745-6215-16-S2-P63
_version_ 1782402743651008512
author Lin, Chien-Ju
Wason, James
author_facet Lin, Chien-Ju
Wason, James
author_sort Lin, Chien-Ju
collection PubMed
description
format Online
Article
Text
id pubmed-4660152
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46601522015-12-02 Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements Lin, Chien-Ju Wason, James Trials Poster Presentation BioMed Central 2015-11-16 /pmc/articles/PMC4660152/ http://dx.doi.org/10.1186/1745-6215-16-S2-P63 Text en Copyright © 2015 Lin and Wason http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Lin, Chien-Ju
Wason, James
Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
title Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
title_full Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
title_fullStr Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
title_full_unstemmed Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
title_short Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
title_sort improving phase ii oncology trial using best observed recist response as an endpoint by modelling continuous tumour measurements
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660152/
http://dx.doi.org/10.1186/1745-6215-16-S2-P63
work_keys_str_mv AT linchienju improvingphaseiioncologytrialusingbestobservedrecistresponseasanendpointbymodellingcontinuoustumourmeasurements
AT wasonjames improvingphaseiioncologytrialusingbestobservedrecistresponseasanendpointbymodellingcontinuoustumourmeasurements

Ejemplares similares